Literature DB >> 29075776

Defining the Prevalence and Prognostic Value of Perineural Invasion and Angiolymphatic Invasion in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

William G Albergotti1, Hannah L Schwarzbach2, Shira Abberbock3, Robert L Ferris1, Jonas T Johnson1, Umamaheswar Duvvuri1,4, Seungwon Kim1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29075776      PMCID： PMC5741479          DOI： 10.1001/jamaoto.2017.2019

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN： 2168-6181            Impact factor:   6.223


× No keyword cloud information.
  34 in total

1.  Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma.

Authors:  Bibi Rahima; Susumu Shingaki; Masaki Nagata; Chikara Saito
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2004-04

Review 2.  Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.

Authors:  Maura L Gillison
Journal:  Semin Oncol       Date:  2004-12       Impact factor: 4.929

3.  Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.

Authors:  Joseph Zenga; Bruce H Haughey; Ryan S Jackson; Douglas R Adkins; John Aranake-Chrisinger; Neel Bhatt; Hiram A Gay; Dorina Kallogjeri; Eliot J Martin; Eric J Moore; Randal C Paniello; Jason T Rich; Wade L Thorstad; Brian Nussenbaum
Journal:  Laryngoscope       Date:  2016-12-23       Impact factor: 3.325

Review 4.  Perineural invasion in oral squamous cell carcinoma: a discussion of significance and review of the literature.

Authors:  Nada O Binmadi; John R Basile
Journal:  Oral Oncol       Date:  2011-08-23       Impact factor: 5.337

5.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Pathologic Markers in Surgically Treated HPV-Associated Oropharyngeal Cancer: Retrospective Study, Systematic Review, and Meta-analysis.

Authors:  Patrick Tassone; Meghan Crawley; Cory Bovenzi; Tingting Zhan; William Keane; David Cognetti; Adam Luginbuhl; Joseph Curry
Journal:  Ann Otol Rhinol Laryngol       Date:  2017-02-16       Impact factor: 1.547

7.  The impact of lymphovascular invasion on survival in oral carcinoma.

Authors:  H B Jones; A Sykes; N Bayman; P Sloan; R Swindell; M Patel; B Musgrove
Journal:  Oral Oncol       Date:  2008-07-11       Impact factor: 5.337

8.  The extracapsular spread of tumors in cervical node metastasis.

Authors:  J T Johnson; E L Barnes; E N Myers; V L Schramm; D Borochovitz; B A Sigler
Journal:  Arch Otolaryngol       Date:  1981-12

9.  Clinicobiological progression and prognosis of oral squamous cell carcinoma in relation to the tumor invasive front: impact on prognosis.

Authors:  Kishore Sandu; Lluís Nisa; Philippe Monnier; Christian Simon; Snezana Andrejevic-Blant; Luc Bron
Journal:  Acta Otolaryngol       Date:  2014-04       Impact factor: 1.494

10.  Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.

Authors:  B H Haughey; P Sinha; D Kallogjeri; R L Goldberg; J S Lewis; J F Piccirillo; R S Jackson; E J Moore; M Brandwein-Gensler; S J Magnuson; W R Carroll; T M Jones; M D Wilkie; A Lau; N S Upile; Jon Sheard; J Lancaster; S Tandon; M Robinson; D Husband; I Ganly; J P Shah; D M Brizel; B O'Sullivan; J A Ridge; W M Lydiatt
Journal:  Oral Oncol       Date:  2016-09-23       Impact factor: 5.337
View more
  6 in total

1.  Evaluation of a Touchless Angiography Suite Computer Controller for Neuroendovascular Procedures.

Authors:  Adam A Dmytriw; Kevin Phan; Jamie Tremaine; Matt Strickland; Ivan Radovanovic; Timo Krings; Vitor M Pereira
Journal:  Clin Neuroradiol       Date:  2019-11-06       Impact factor: 3.649

2.  Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.

Authors:  John D Cramer; Robert L Ferris; Seungwon Kim; Umamaheswar Duvvuri
Journal:  Oral Oncol       Date:  2018-11-13       Impact factor: 5.337

3.  TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS.

Authors:  Mihir R Patel; Lauren Ottenstein; Martha Ryan; Annie Farrell; Matthew Studer; H Michael Baddour; Kelly Magliocca; Christopher Griffith; William Stokes; Jeffrey Switchenko; Ashley Aiken; Mark El-Deiry; C Arturo Solares; Conor Steuer; Nabil Saba; Jonathan Beitler
Journal:  Oral Oncol       Date:  2021-04-17       Impact factor: 5.337

4.  Adjuvant Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Carcinoma with Adverse Pathological Features.

Authors:  Shady I Soliman; Farhoud Faraji; John Pang; Loren K Mell; Joseph A Califano; Ryan K Orosco
Journal:  Cancers (Basel)       Date:  2022-09-17       Impact factor: 6.575

5.  Widespread expression of Sonic hedgehog (Shh) and Nrf2 in patients treated with cisplatin predicts outcome in resected tumors and are potential therapeutic targets for HPV-negative head and neck cancer.

Authors:  Abu Shadat M Noman; Rashed R Parag; Muhammad I Rashid; Mohammad Z Rahman; Ali A Chowdhury; Afrin Sultana; Chandsultana Jerin; Ayesha Siddiqua; Lutfur Rahman; Afsana Shirin; Junayed Nayeem; Reaz Mahmud; Sonam Akther; Rajib K Shil; Ikram Hossain; Sharmin Alam; Arfina Chowdhury; Shabnam B Basher; Abul Hasan; Shammy Bithy; Jannatul Aklima; Mizanur Rahman; Nabila Chowdhury; Tahmina Banu; Bedri Karakas; Herman Yeger; Walid A Farhat; Syed S Islam
Journal:  Ther Adv Med Oncol       Date:  2020-03-13       Impact factor: 8.168

Review 6.  HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.

Authors:  Matt Lechner; Jacklyn Liu; Liam Masterson; Tim R Fenton
Journal:  Nat Rev Clin Oncol       Date:  2022-02-01       Impact factor: 65.011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.